Hyperglycaemia in Pregnancy (HIP) is a global issue as it increases risks for both the mother and child. There remains considerable disparity in clinical practice and national policies for HIP screening. FIGO, EBCOG and EAPM have joined forces to address this disparity in clinical care and reduce the burden of inter-generational Non-Communicable disease.
|Number of pages||2|
|Journal||European Journal of Obstetrics, Gynecology and Reproductive Biology|
|State||Published - Sep 2018|